Skip to main content
OpenTrials

Clinical trial condition

Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative

Explore clinical trials studying Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative trial results

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations